Merck & Co. (MRK) Q3 2017 Results - Earnings Call Transcript

10/30/17

Merck & Co., Inc. (NYSE:MRK)

Q3 2017 Earnings Call

October 27, 2017 8:00 am ET

Executives

Teri Loxam - Merck & Co., Inc.

Kenneth C. Frazier - Merck & Co., Inc.

Robert M. Davis - Merck & Co., Inc.

Adam H. Schechter - Merck & Co., Inc.

Roger M. Perlmutter - Merck & Co., Inc.

Analysts

Andrew S. Baum - Citigroup Global Markets Ltd.

Alexander Man - Sanford C. Bernstein & Co. LLC

Chris Schott - JPMorgan Securities LLC

David R. Risinger - Morgan Stanley & Co. LLC

Steve Scala - Cowen and Co. LLC

Alex Arfaei - BMO Capital Markets (United States)

Gregg Gilbert - Deutsche Bank Securities, Inc.

Vamil K. Divan - Credit Suisse Securities (NYSE:USA) LLC

Geoffrey Meacham - Barclays Capital, Inc.

Umer Raffat - Evercore ISI

Jami Rubin - Goldman Sachs & Co. LLC

Operator

Good morning. My name is Darla, and I will be your conference operator today. At this time, I'd like to welcome everyone to Merck's Q3 2017 Sales and Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. Thank you.

I would now like to turn the call over to Teri Loxam. Please go ahead.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.